NCT04802174 2026-03-17Lurbinectedin With Berzosertib, an ATR Kinase Inhibitor in Small Cell Cancers and High-Grade Neuroendocrine CancersNational Institutes of Health Clinical Center (CC)Phase 1/2 Active not recruiting37 enrolled
NCT05091567 2026-03-10IMforteHoffmann-La RochePhase 3 Active not recruiting660 enrolled 23 charts 1 FDA